CASI Pharmaceuticals
CASI
#9763
Rank
NZ$60.9 M
Marketcap
$3.93
Share price
0.67%
Change (1 day)
-47.53%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -NZ$48.31 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are NZ$22.05 Million. In 2023 the company made an earning of -NZ$46.29 Million, an increase over its 2022 earnings that were of -NZ$65.7 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$48.31 Million4.38%
2023 -NZ$46.29 Million-29.55%
2022 -NZ$65.7 Million4.43%
2021 -NZ$62.91 Million-24.56%
2020 -NZ$83.39 Million4.74%
2019 -NZ$79.62 Million65.13%
2018 -NZ$48.22 Million155.07%
2017 -NZ$18.91 Million13.93%
2016 -NZ$16.6 Million31.18%
2015 -NZ$12.65 Million-72.5%
2014 -NZ$45.99 Million356.62%
2013 -NZ$10.08 Million-60.55%
2012 -NZ$25.53 Million218.41%
2011 -NZ$8.02 Million0.74%
2010 -NZ$7.96 Million-32.54%
2009 -NZ$11.8 Million-66.98%
2008 -NZ$35.73 Million-14.22%
2007 -NZ$41.65 Million7.04%
2006 -NZ$38.91 Million27.95%
2005 -NZ$30.41 Million4.51%
2004 -NZ$29.1 Million-15.84%
2003 -NZ$34.58 Million-55.29%
2002 -NZ$77.34 Million-34.05%
2001 -NZ$0.12 Billion31.73%
2000 -NZ$89.01 Million31.56%
1999 -NZ$67.66 Million145.56%
1998 -NZ$27.56 Million76.4%
1997 -NZ$15.62 Million36.92%
1996 -NZ$11.41 Million